Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables - Net (2024 - 2025)

Historic Receivables - Net for Gossamer Bio (GOSS) over the last 2 years, with Q3 2025 value amounting to $9.2 million.

  • Gossamer Bio's Receivables - Net rose 4030.05% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 4030.05%. This contributed to the annual value of $5.3 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Gossamer Bio's Receivables - Net stood at $9.2 million, which was up 4030.05% from $7.6 million recorded in Q2 2025.
  • Gossamer Bio's Receivables - Net's 5-year high stood at $9.2 million during Q3 2025, with a 5-year trough of $3.6 million in Q2 2024.